ゲノムデータ解析および解読の世界市場：2033年までの機会と戦略

世界のゲノムデータ解析および解読市場は2018年に9億9,947万米ドルと評価され、2023年まで11.00％以上のCAGRで成長しました。

研究開発への投資拡大

これまでのゲノムデータ解析および解読市場は主に研究開発への投資の拡大によって牽引されました。研究開発（R&D）への投資は、技術の進歩、世界的競争、市場需要、規制圧力、世界的課題、資本へのアクセス、長期的成長と競争力の主な促進要因としての研究開発の認識などにより増加しています。この投資は、新しいデリバリーシステムの開発、ターゲティング能力の向上、安全性プロファイルの改善、応用範囲の拡大など、遺伝子デリバリー技術に役立っており、最終的には、遺伝性疾患やがんなど、さまざまな疾患に対するより効果的で個別化された治療につながります。例えば、米国の政府機関National Center for Science and Engineering Statisticsによると、2022年に州政府機関が研究開発（R&D）に支出した総額は26億4,400万米ドルと報告されています。これは、前年度の25億1,300万米ドルから5.2％の増加です。さらに、米国の生物医学図書館National Library of MedicineによるClinicalTrials.gov Modernization Effort Report 2021-2022によると、2022年にClinicalTrials.govに登録された臨床試験、観察研究、拡大アクセスプログラムは440,400件で、2021年の403,188件から増加しています。したがって、ゲノムデータ解析および解読市場は、主に研究開発への投資の拡大によって牽引されました。

目次

第1章 エグゼクティブサマリー

• ゲノムデータの分析と解釈-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

• 一般的な市場の定義
• 概要
• ゲノムデータ解析および解読市場定義とセグメンテーション
• 市場セグメンテーション：製品別
  • ソフトウェア
  • サービス
• 市場セグメンテーション：用途別
  • 機能ゲノミクス
  • エピゲノミクス
  • パスウェイ分析
  • バイオマーカーの発見
  • その他の用途
• 市場セグメンテーション：エンドユーザー別
  • 製薬およびバイオテクノロジー企業
  • 病院および診断研究所
  • 研究・学術機関
  • その他のエンドユーザー

第7章 主要な市場動向

• より高速で正確なゲノムデータ分析を実現するライトスピード技術の進歩
• 革新的なゲノムプロファイリングツールが精密医療と個別化がん治療を変革
• RNAseqデータ分析の進歩により遺伝子発現研究と精密医療が強化される
• 次世代シーケンシングプラットフォームがゲノム調査と診断の精度とアクセス性を向上
• 主要企業間の戦略的パートナーシップとコラボレーションにより製品ラインナップを強化

第8章 ゲノムデータ解析および解読市場：マクロ経済シナリオ

• COVID-19の影響：ゲノムデータ解析および解読市場
• ウクライナ戦争の影響：ゲノムデータ解析および解読市場
• 高インフレの影響：ゲノムデータ解析および解読市場

第9章 世界の市場規模と成長

• 市場規模
• 市場成長実績、2018-2023
  • 市場促進要因、2018-2023
  • 市場抑制要因、2018-2023
• 市場成長予測、2023-2028、2033F
  • 市場促進要因、2023-2028
  • 市場抑制要因、2023-2028

第10章 世界のゲノムデータ解析および解読市場：セグメンテーション

• 世界のゲノムデータ解析および解読市場：製品別、実績と予測, 2018-2023, 2028F, 2033F
• 世界のゲノムデータ解析および解読市場：用途別、実績と予測, 2018-2023, 2028F, 2033F
• 世界のゲノムデータ解析および解読市場：エンドユーザー別、実績と予測, 2018-2023, 2028F, 2033F

第11章 ゲノムデータ解析および解読市場：地域・国別分析

• 世界のゲノムデータ解析および解読市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
• 世界のゲノムデータ解析および解読市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

• 企業プロファイル
• Syngenta AG
• Amgen Inc
• Monsanto（Bayer）AG
• Illumina Inc.
• F. Hoffman-La Roche Ltd

第20章 その他の大手企業と革新的企業

• Eurofins Scientific SE
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Oxford Nanopore Technologies Inc.
• Thermo Fisher Scientific Inc.
• QIAGEN N.V.
• Deep Genomics Inc.
• Genomics England Ltd.
• 23andMe Holding Co.
• Beijing Genomics Institute（BGI）Genomics Co. Ltd.
• DNAnexus Inc.
• Seven Bridges Genomics
• Novogene
• MedGenome
• Sophia Genetics

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

第24章 機会と戦略

• 世界のゲノムデータ解析および解読市場2028：新たな機会を提供する国
• 世界のゲノムデータ解析および解読市場2028：新たな機会を提供するセグメント
• 世界のゲノムデータ解析および解読市場2028：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第25章 ゲノムデータ解析および解読市場：結論と提言

• 結論
• 提言
  • 製品
  • 場所
  • 価格
  • プロモーション
  • 人々

第26章 付録

Genomic data analysis and interpretation involve the process of analyzing the vast amount of information contained in an organism's deoxyribonucleic acid (DNA) to understand its structure, function and variations. This field uses computational tools, bioinformatics and statistical methods to process raw genomic data, such as sequences of nucleotides and interpret their biological significance.

The genomic data analysis and interpretation market consists of sales, by entities (organizations, sole traders, or partnerships), of products and services that facilitate the examination and understanding of genomic data derived from sequencing technologies.

The global genomic data analysis and interpretation market was valued at $999.47 million in 2018 which grew up till 2023 at a compound annual growth rate (CAGR) of more than 11.00%.

Growing Investments In Research And Development

During the historic period, the genomic data analysis and interpretation market was mainly driven by the growing investments in research and development. The investment in research and development (R&D) is growing due to technological advancements, global competition, market demand, regulatory pressures, global challenges, access to capital and the recognition of R&D as a key driver of long-term growth and competitiveness. This investment helps gene delivery technologies by enabling the development of new and improved delivery systems, enhancing targeting capabilities, improving safety profiles and expanding the range of applications, ultimately leading to more effective and personalized treatments for various diseases, including genetic disorders and cancer. For instance, according to the National Center for Science and Engineering Statistics, a US-based government agency, in 2022, state government agencies reported a total expenditure of $2.644 billion on research and experimental development (R&D). This represents a 5.2% increase from the previous year's expenditures of $2.513 billion. Further, According to the ClinicalTrials.gov Modernization Effort Report 2021-2022 by National Library of Medicine, a US-based biomedical library, in 2022, there were 440,400 clinical trials, observational studies and expanded access programs listed on ClinicalTrials.gov, showing a rise from the 403,188 registered studies in 2021. Therefore, the genomic data analysis and interpretation market was mainly driven by the growing investments in research and development.

Advancements In Lightspeed Technology For Faster And More Accurate Genomic Data Analysis

Major companies in the genomic data analysis and interpretation market are focusing on developing innovative products like lightspeed technology, to enhance the speed and accuracy of genetic data processing and interpretation for advanced healthcare solutions. Lightspeed technology refers to advanced computational tools and platforms that significantly accelerate the processing and analysis of genomic data. Lightspeed technology leverages high-performance computing and advanced algorithms to accelerate data throughput, which is crucial for handling the large volumes of data generated in genomic research and clinical diagnostics. For instance, in January 2024, QIAGEN N.V., a Germany-based company provider of sample and assay technologies for molecular diagnostics, applied testing, academic research and pharmaceutical research, launched ultra-fast next-generation sequencing (NGS) analysis for somatic cancer. The new software accelerator substantially cuts both time and cost for secondary analysis of NGS in somatic cancer. It can analyze a comprehensive 275-gene cancer panel at 3377x coverage in just 6 minutes, with a cost of less than $0.72 per test.

The global genomic data analysis and interpretation market is fairly fragmented, with large number of small players operating in the market. The top ten competitors in the market made up to 14.93% of the total market in 2023.

Genomic Data Analysis And Interpretation Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the genomic data analysis and interpretation market as it emerges from the COVID-19 shut down.

Reasons to Purchase:

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for genomic data analysis and interpretation? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The genomic data analysis and interpretation market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider genomic data analysis and interpretation market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by application and by end-user.
• Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario - The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the genomic data analysis and interpretation market.

Global Market Size And Growth - Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies - Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for genomic data analysis and interpretation providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Product: Software; Services
• 2) By Application: Functional Genomics; Epigenomics; Pathway Analysis; Biomarker Discovery; Other Applications
• 3) By End-User: Pharmaceutical And Biotechnology Companies; Hospitals And Diagnostic Laboratories; Research And Academic Institutes; Other End-Users
• Companies Mentioned: Syngenta Group; Amgen Inc; Monsanto (Bayer) AG; Illumina Inc; F. Hoffmann-La Roche Ltd. (Genentech)
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; genomic data analysis and interpretation indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Genomic Data Analysis And Interpretation - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Genomic Data Analysis And Interpretation Market Definition And Segmentations
• 6.4 Market Segmentation By Product
  • 6.4.1 Software
  • 6.4.2 Services
• 6.5 Market Segmentation By Application
  • 6.5.1 Functional Genomics
  • 6.5.2 Epigenomics
  • 6.5.3 Pathway Analysis
  • 6.5.4 Biomarker Discovery
  • 6.5.5 Other Applications
• 6.6 Market Segmentation By End-User
  • 6.6.1 Pharmaceutical And Biotechnology Companies
  • 6.6.2 Hospitals And Diagnostic Laboratories
  • 6.6.3 Research And Academic Institutes
  • 6.6.4 Other End-Users

7 Major Market Trends

• 7.1 Advancements In Lightspeed Technology For Faster And More Accurate Genomic Data Analysis
• 7.2 Innovative Genomic Profiling Tools Transforming Precision Medicine and Personalized Cancer Care
• 7.3 Advancements In RNAseq Data Analysis Enhance Gene Expression Studies And Precision Medicine
• 7.4 Next-Generation Sequencing Platform Enhances Precision And Accessibility In Genomic Research And Diagnostics
• 7.5 Strategic Partnerships And Collaborations Among Major Players To Enhance Product Offerings

8 Genomic Data Analysis And Interpretation Market - Macro Economic Scenario

• 8.1 COVID-19 Impact On The Genomic Data Analysis And Interpretation Market
• 8.2 Impact Of The War In Ukraine On The Genomic Data Analysis And Interpretation Market
• 8.3 Impact Of High Inflation On The Genomic Data Analysis And Interpretation Market

9 Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Genomic Data Analysis And Interpretation Market Segmentation

• 10.1 Global Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Genomic Data Analysis And Interpretation Market, Regional and Country Analysis

• 11.1 Global Genomic Data Analysis And Interpretation Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Genomic Data Analysis And Interpretation Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate Tax Structure
  • 12.2.10 Investments
  • 12.2.11 Major Companies
• 12.3 Asia Pacific Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia Pacific Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia Pacific Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.6 Asia-Pacific Genomic Data Analysis And Interpretation Market: Country Analysis
• 12.7 China Market
• 12.8 Summary
• 12.9 Market Overview
  • 12.9.1 Country Information
  • 12.9.2 Market Information
  • 12.9.3 Background Information
  • 12.9.4 Government Initiatives
  • 12.9.5 Regulations
  • 12.9.6 Regulatory Bodies
  • 12.9.7 Major Associations
  • 12.9.8 Taxes Levied
  • 12.9.9 Corporate Tax Structure
  • 12.9.10 Major Companies
• 12.10 China Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 China Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.12 China Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Market
• 12.14 India Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 India Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.16 India Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan Market
• 12.18 Japan Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Japan Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.20 Japan Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia Market
• 12.22 Australia Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Australia Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.24 Australia Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia Market
• 12.26 Indonesia Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 Indonesia Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.28 Indonesia Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea Market
• 12.30 South Korea Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.31 South Korea Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.32 South Korea Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate tax structure
  • 13.2.10 Investments
  • 13.2.11 Major Companies
• 13.3 Western Europe Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.6 Western Europe Genomic Data Analysis And Interpretation Market: Country Analysis
• 13.7 UK Market
• 13.8 UK Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 UK Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.11 Germany Market
• 13.12 Germany Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 Germany Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.15 France Market
• 13.16 France Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 France Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.19 Italy Market
• 13.20 Italy Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Italy Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.23 Spain Market
• 13.24 Spain Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.26 Spain Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Major companies
• 14.3 Eastern Europe Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.6 Eastern Europe Genomic Data Analysis And Interpretation Market: Country Analysis
• 14.7 Russia Market
• 14.8 Russia Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.10 Russia Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulations
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Investments
  • 15.2.11 Major Companies
• 15.3 North America Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.6 North America Genomic Data Analysis And Interpretation Market: Country Analysis
• 15.7 USA Market
• 15.8 Summary
• 15.9 Market Overview
  • 15.9.1 Country Information
  • 15.9.2 Market Information
  • 15.9.3 Background Information
  • 15.9.4 Government Initiatives
  • 15.9.5 Regulations
  • 15.9.6 Regulatory Bodies
  • 15.9.7 Major Associations
  • 15.9.8 Taxes Levied
  • 15.9.9 Corporate Tax Structure
  • 15.9.10 Investments
  • 15.9.11 Major Companies
• 15.1 USA Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 USA Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.12 USA Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada Market
• 15.14 Canada Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.15 Canada Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.16 Canada Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Investments
  • 16.2.11 Major Companies
• 16.3 South America Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.6 South America Genomic Data Analysis And Interpretation Market: Country Analysis
• 16.7 Brazil Market
• 16.8 Brazil Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.10 Brazil Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Major Companies
• 17.3 Middle East Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.5 Middle East Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
• 18.2 Market Overview
  • 18.2.1 Region Information
  • 18.2.2 Market Information
  • 18.2.3 Background Information
  • 18.2.4 Government Initiatives
  • 18.2.5 Regulations
  • 18.2.6 Regulatory Bodies
  • 18.2.7 Major Associations
  • 18.2.8 Taxes Levied
  • 18.2.9 Corporate Tax Structure
  • 18.2.10 Major Companies
• 18.3 Africa Genomic Data Analysis And Interpretation Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Genomic Data Analysis And Interpretation Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.5 Africa Genomic Data Analysis And Interpretation Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape and Company Profiles

• 19.1 Company Profiles
• 19.2 Syngenta AG
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 Amgen Inc
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 Monsanto (Bayer) AG
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Financial Overview
• 19.5 Illumina Inc.
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview
• 19.6 F. Hoffman-La Roche Ltd
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Financial Overview

20 Other Major And innovative Companies

• 20.1 Eurofins Scientific SE
  • 20.1.1 Company Overview
  • 20.1.2 Products And Services
• 20.2 Agilent Technologies Inc.
  • 20.2.1 Company Overview
  • 20.2.2 Products And Services
• 20.3 Bio-Rad Laboratories Inc.
  • 20.3.1 Company Overview
  • 20.3.2 Products And Services
• 20.4 Oxford Nanopore Technologies Inc.
  • 20.4.1 Company Overview
  • 20.4.2 Products And Services
• 20.5 Thermo Fisher Scientific Inc.
  • 20.5.1 Company Overview
  • 20.5.2 Products And Services
• 20.6 QIAGEN N.V.
  • 20.6.1 Company Overview
  • 20.6.2 Products And Services
• 20.7 Deep Genomics Inc.
  • 20.7.1 Company Overview
  • 20.7.2 Products & Services
• 20.8 Genomics England Ltd.
  • 20.8.1 Company Overview
  • 20.8.2 Products And Services
• 20.9 23andMe Holding Co.
  • 20.9.1 Company Overview
  • 20.9.2 Products And Services
• 20.10 Beijing Genomics Institute (BGI) Genomics Co. Ltd.
  • 20.10.1 Company Overview
  • 20.10.2 Products And Services
• 20.11 DNAnexus Inc.
  • 20.11.1 Company Overview
  • 20.11.2 Products And Services
• 20.12 Seven Bridges Genomics
  • 20.12.1 Company Overview
  • 20.12.2 Products And Services
• 20.13 Novogene
  • 20.13.1 Company Overview
  • 20.13.2 Products And Services
• 20.14 MedGenome
  • 20.14.1 Company Overview
  • 20.14.2 Products And Services
• 20.15 Sophia Genetics
  • 20.15.1 Company Overview
  • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

• 23.1 Biomerieux Acquired Neoprospecta To Enhance Diagnostics With Advanced Genomic Technologies
• 23.2 Illumina Acquired Fluent Biosciences To Enhance RNA Sequencing And Precision Medicine Capabilities
• 23.3 BC Platforms Acquired Medexprim To Strengthen Clinical And Imaging Data Access Across Europe

24 Opportunities And Strategies

• 24.1 Global Genomic Data Analysis And Interpretation Market In 2028 - Countries Offering Most New Opportunities
• 24.2 Global Genomic Data Analysis And Interpretation Market In 2028 - Segments Offering Most New Opportunities
• 24.3 Global Genomic Data Analysis And Interpretation Market In 2028 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Genomic Data Analysis And Interpretation Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer